Golden Sun (NASDAQ: GSUN) plans Sept. 2025 shareholder meetings, mails proxy materials

Rhea-AI Filing Summary

Golden Sun Health Technology Group Limited is notifying investors about upcoming shareholder meetings and related proxy materials. The company will hold an extraordinary general meeting for holders of Class A ordinary shares on September 25, 2025, followed by its 2025 annual general meeting of shareholders on the same date.

The company is distributing a combined notice and proxy statement for Class A shareholders and a separate notice and proxy statement for Class B shareholders, both dated August 15, 2025. It is also providing proxy cards for Class A and Class B holders so they can vote on the matters to be presented at these meetings.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

––––––––––––––––––––––––––––––––––

FORM 6-K

––––––––––––––––––––––––––––––––––

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-41425

––––––––––––––––––––––––––––––––––

Golden Sun Health Technology Group Limited
金太阳健康科技集团有限公司 (Translation of registrant’s name into English)

––––––––––––––––––––––––––––––––––

Room 503, Building C2, No. 1599
Xinjinqiao Road, Pudong New Area
Shanghai, China
(Address of principal executive office)

––––––––––––––––––––––––––––––––––

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

The extraordinary general meeting of holders of Class A ordinary shares of Golden Sun Health Technology Group Limited, a company incorporated under the laws of the Cayman Islands (the “Company”), will be held on September 25, 2025, followed by the 2025 annual general meeting of shareholders of the Company (together with the extraordinary general meeting of holders of Class A ordinary shares, the “Meetings”). In connection with the Meetings, the Company hereby furnishes the following documents:

Attached as Exhibit 99.1 to this Report are the Combined Notice and Proxy Statement of the Extraordinary General Meeting of holders of Class A ordinary shares of the Company and the 2025 Annual General Meeting of holders of ordinary shares of the Company, dated August 15, 2025, to be mailed to holders of Class A ordinary shares of the Company.

Attached as Exhibit 99.2 to this Report is the Notice and Proxy Statement of the 2025 Annual General Meeting of holders of ordinary shares of the Company, dated August 15, 2025, to be mailed to holders of Class B ordinary shares of the Company.

Attached as Exhibit 99.3 to this Report is Form of Proxy Card to be mailed to holders of Class A ordinary shares of the Company for use in connection with the Extraordinary General Meeting of holders of Class A ordinary shares of the Company.

Attached as Exhibit 99.4 to this Report is Form of Proxy Card to be mailed to holders of ordinary shares of the Company for use in connection with the 2025 Annual General Meeting of Shareholders of the Company.

1

Exhibits

Exhibit No.		Description
99.1		Combined Notice and Proxy Statement of the Extraordinary General Meeting of holders of Class A ordinary shares of the Company and the 2025 Annual General Meeting of holders of ordinary shares of the Company, dated August 15, 2025, to be mailed to holders of Class A ordinary shares of the Company.
99.2		Notice and Proxy Statement of the 2025 Annual General Meeting of holders of ordinary shares of the Company, dated August 15, 2025, to be mailed to holders of Class B ordinary shares of the Company.
99.3		Form of Proxy Card to be mailed to holders of Class A ordinary shares of the Company for use in connection with the Extraordinary General Meeting of holders of Class A Ordinary Shares of the Company.
99.4		Form of Proxy Card to be mailed to holders of ordinary shares of the Company for use in connection with the 2025 Annual General Meeting of Shareholders of the Company.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Golden Sun Health Technology Group Limited
Date: August 15, 2025		By:		/s/ Xueyuan Weng
		Name:		Xueyuan Weng
		Title:		Chief Executive Officer

3

FAQ

What did Golden Sun Health Technology Group Limited (GSUN) disclose in this 6-K?

The company disclosed that it will hold an extraordinary general meeting for Class A ordinary shareholders and its 2025 annual general meeting of shareholders on September 25, 2025, and is furnishing the related notices, proxy statements, and proxy cards.

When are Golden Sun Health Technology Group Limited’s 2025 shareholder meetings scheduled?

The extraordinary general meeting of holders of Class A ordinary shares and the 2025 annual general meeting of shareholders of Golden Sun Health Technology Group Limited are scheduled for September 25, 2025.

What documents are being provided to Golden Sun (GSUN) Class A shareholders?

Class A shareholders will receive a Combined Notice and Proxy Statement for the extraordinary general meeting and the 2025 annual general meeting, dated August 15, 2025, along with a Form of Proxy Card for use at the extraordinary general meeting.

What documents are being provided to Golden Sun (GSUN) Class B shareholders?

Class B shareholders will receive a separate Notice and Proxy Statement for the 2025 annual general meeting, dated August 15, 2025, together with a Form of Proxy Card for use at the 2025 annual general meeting.

Why is Golden Sun Health Technology Group Limited sending proxy cards?

Proxy cards are being sent so holders of Class A and Class B ordinary shares of Golden Sun Health Technology Group Limited can appoint proxies and vote on the matters to be considered at the extraordinary and annual general meetings.

Where is Golden Sun Health Technology Group Limited headquartered?

Golden Sun Health Technology Group Limited lists its principal executive office at Room 503, Building C2, No. 1599 Xinjinqiao Road, Pudong New Area, Shanghai, China.